Artificial saliva for therapeutic management of xerostomia: A narrative review
In clinical practice, xerostomia or oral dryness is a chronic disease condition encountered by most dentists and dental hygienists, which often causes a negative impact on the oral health-related quality of life of the affected individual. Xerostomia is caused due to salivary gland dysfunction. It i...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer Medknow Publications
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/faa7699f293d457ebbc3596b52fac668 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:faa7699f293d457ebbc3596b52fac668 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:faa7699f293d457ebbc3596b52fac6682021-11-19T12:15:51ZArtificial saliva for therapeutic management of xerostomia: A narrative review0975-740610.4103/jpbs.jpbs_236_21https://doaj.org/article/faa7699f293d457ebbc3596b52fac6682021-01-01T00:00:00Zhttp://www.jpbsonline.org/article.asp?issn=0975-7406;year=2021;volume=13;issue=6;spage=903;epage=907;aulast=Alhejouryhttps://doaj.org/toc/0975-7406In clinical practice, xerostomia or oral dryness is a chronic disease condition encountered by most dentists and dental hygienists, which often causes a negative impact on the oral health-related quality of life of the affected individual. Xerostomia is caused due to salivary gland dysfunction. It is related to reduced salivary secretion or the absence of saliva flow, more frequently, exhibits qualitative changes in saliva proteins and immunoglobulin concentrations that arise due to salivary gland dysfunction. This condition causes discomfort and interferes with normal oral activities, and affected individuals are at high caries risk. There are several options for treatment and symptom management: salivary stimulants, topical agents, saliva substitutes, and systemic sialogogues. This review explores the current status of therapeutic management of patients affected by xerostomia and hyposalivation using artificial saliva.Hajer Ayed AlhejouryLina Fouad MogharbelMohammed Ahmed Al-QadhiSuzan Sulaiman ShamlanAmal Fuad AlturkiWafaa Mohammed BabatinRenad Abdualrahman Mohammed AlaishanFawaz PullisheryWolters Kluwer Medknow Publicationsarticleminimally invasive dentistryrheologysaliva alternativesxerostomiaPharmacy and materia medicaRS1-441Analytical chemistryQD71-142ENJournal of Pharmacy and Bioallied Sciences, Vol 13, Iss 6, Pp 903-907 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
minimally invasive dentistry rheology saliva alternatives xerostomia Pharmacy and materia medica RS1-441 Analytical chemistry QD71-142 |
spellingShingle |
minimally invasive dentistry rheology saliva alternatives xerostomia Pharmacy and materia medica RS1-441 Analytical chemistry QD71-142 Hajer Ayed Alhejoury Lina Fouad Mogharbel Mohammed Ahmed Al-Qadhi Suzan Sulaiman Shamlan Amal Fuad Alturki Wafaa Mohammed Babatin Renad Abdualrahman Mohammed Alaishan Fawaz Pullishery Artificial saliva for therapeutic management of xerostomia: A narrative review |
description |
In clinical practice, xerostomia or oral dryness is a chronic disease condition encountered by most dentists and dental hygienists, which often causes a negative impact on the oral health-related quality of life of the affected individual. Xerostomia is caused due to salivary gland dysfunction. It is related to reduced salivary secretion or the absence of saliva flow, more frequently, exhibits qualitative changes in saliva proteins and immunoglobulin concentrations that arise due to salivary gland dysfunction. This condition causes discomfort and interferes with normal oral activities, and affected individuals are at high caries risk. There are several options for treatment and symptom management: salivary stimulants, topical agents, saliva substitutes, and systemic sialogogues. This review explores the current status of therapeutic management of patients affected by xerostomia and hyposalivation using artificial saliva. |
format |
article |
author |
Hajer Ayed Alhejoury Lina Fouad Mogharbel Mohammed Ahmed Al-Qadhi Suzan Sulaiman Shamlan Amal Fuad Alturki Wafaa Mohammed Babatin Renad Abdualrahman Mohammed Alaishan Fawaz Pullishery |
author_facet |
Hajer Ayed Alhejoury Lina Fouad Mogharbel Mohammed Ahmed Al-Qadhi Suzan Sulaiman Shamlan Amal Fuad Alturki Wafaa Mohammed Babatin Renad Abdualrahman Mohammed Alaishan Fawaz Pullishery |
author_sort |
Hajer Ayed Alhejoury |
title |
Artificial saliva for therapeutic management of xerostomia: A narrative review |
title_short |
Artificial saliva for therapeutic management of xerostomia: A narrative review |
title_full |
Artificial saliva for therapeutic management of xerostomia: A narrative review |
title_fullStr |
Artificial saliva for therapeutic management of xerostomia: A narrative review |
title_full_unstemmed |
Artificial saliva for therapeutic management of xerostomia: A narrative review |
title_sort |
artificial saliva for therapeutic management of xerostomia: a narrative review |
publisher |
Wolters Kluwer Medknow Publications |
publishDate |
2021 |
url |
https://doaj.org/article/faa7699f293d457ebbc3596b52fac668 |
work_keys_str_mv |
AT hajerayedalhejoury artificialsalivafortherapeuticmanagementofxerostomiaanarrativereview AT linafouadmogharbel artificialsalivafortherapeuticmanagementofxerostomiaanarrativereview AT mohammedahmedalqadhi artificialsalivafortherapeuticmanagementofxerostomiaanarrativereview AT suzansulaimanshamlan artificialsalivafortherapeuticmanagementofxerostomiaanarrativereview AT amalfuadalturki artificialsalivafortherapeuticmanagementofxerostomiaanarrativereview AT wafaamohammedbabatin artificialsalivafortherapeuticmanagementofxerostomiaanarrativereview AT renadabdualrahmanmohammedalaishan artificialsalivafortherapeuticmanagementofxerostomiaanarrativereview AT fawazpullishery artificialsalivafortherapeuticmanagementofxerostomiaanarrativereview |
_version_ |
1718420171257806848 |